A Home-based Blood Pressure Monitoring Program to Promote Better Management of Hypertension
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this study the investigators aim to evaluate the effect of home-based blood pressure measurement with an electronic device on medication adherence and blood pressure control.
| Condition | Intervention |
|---|---|
|
Hypertension |
Behavioral: Self monitoring of blood pressure Other: Usual Care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Home-based Blood Pressure Measurement Program in Hypertensive Patients to Promote Medications Adherence and Blood Pressure Status. |
- Blood pressure-24 weeks [ Time Frame: Change from baseline(at the point of recruiting) blood pressure at 24 weeks. ] [ Designated as safety issue: No ]Blood pressure is measured twice by trained nurses using hand-cuff device at the physician office. (in Hg millimeter)
- Medication adherence-4 weeks [ Time Frame: Change from baseline(at the point of recruiting) medication adherence at 4 weeks ] [ Designated as safety issue: No ]
- Blood pressure- 4 weeks [ Time Frame: Change from baseline(at the point of recruiting) blood pressure at 4 weeks. ] [ Designated as safety issue: No ]
- Blood pressure- 12 weeks [ Time Frame: Change from baseline(at the point of recruiting) blood pressure at 12 weeks. ] [ Designated as safety issue: No ]
- Medication adherence- 12 weeks [ Time Frame: Change from baseline(at the point of recruiting) medication adherence at 12 weeks ] [ Designated as safety issue: No ]
- Medication adherence-24 weeks [ Time Frame: Change from baseline(at the point of recruiting) medication adherence at 24 weeks ] [ Designated as safety issue: No ]Pill count method is employed. At the time of each office visit, patients bring their medications with themselves and the researcher counts the unused pills. Adherence is calculated as percentage of the pills used during previous weeks.
| Estimated Enrollment: | 196 |
| Study Start Date: | March 2012 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Home-based blood pressure monitoring |
Behavioral: Self monitoring of blood pressure
Electronic blood pressure device is provided for patients and he/she will be trained to measure blood pressure at home once daily(same time each day). A logbook is also provided to document the daily blood pressure level.
|
| Active Comparator: Usual care |
Other: Usual Care
Four visits to the physician's office at 4th, 12th, 24th week in the study period with usual advice giving practice of the staff. At the end of the trial period, an electronic blood pressure device will be given to each patient in this arm.
|
Detailed Description:
Adherence to treatment is disappointingly low among patients with chronic health disorders especially after 6 month of initiating drug therapy. In hypertensive patients , as reported by WHO, 50% of non-adherence could be expected. Poor adherence to anti hypertensive medications results in increased morbidity, mortality and costs. One of the reasons that could implicate medications adherence can be attributed to seeing no physical sign of better controlling blood pressure. Self monitoring of blood pressure at home has been reported to improve patients adherence to their medications.
This study is a 2-arm randomized controlled trial. The investigators aim to evaluate the effect of home-based blood pressure measurement with an electronic device on medication adherence and blood pressure status.
One hundred ninety six hypertensive patients aged at least 18 years old are recruited in an ambulatory care setting and are evenly allocated to the study arms with balanced-block telephone randomization.
Appropriate medication is prescribed as preferred by the cardiologist (single daily dose medicines are recommended). Patients in both arms are followed for 24 weeks, each will be visited by the cardiologist four times during the study period. In each visit, patients' blood pressure will be measured twice by a nurse in the office.
In the intervention arm, electronic blood pressure device is provided for each patient and he/she will be trained to measure blood pressure at home once daily (same time each day). A logbook is also provided to document the daily blood pressure level.
Primary outcome of the study is the blood pressure measured at each office visit overtime. Medication adherence is measured by pill count method as the secondary outcome.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ambulatory patients older than 18
- Patients newly diagnosed as hypertension stage 1
- Patients previously on antihypertensive treatment but uncontrolled hypertension
- Patients not possessing electronic self blood pressure measurement device
- Patients with functional ability to use the device
Exclusion Criteria:
- Patients requiring two or more antihypertensive drugs at the start of the study
- Patients with secondary hypertension
- Patients cardiovascular comorbidities and other interfering medical conditions
- Patients with drug contraindication or documented drug allergy
- Patients with serum creatinine > 150 microliters
Withdrawal criteria:
- Inadequate therapeutic effect requiring an increase of more than 20% in pre-established number of visits
- Emergence of adverse drug reactions requiring cessation of medication
Contacts and Locations| Contact: Zahra Jahangard-Rafsanjani, PharmD | 00982188814157 | zjahangard@razi.tums.ac.ir |
| Contact: Amir Sarayani, PharmD, MPH | a-sarayanib@razi.tums.ac.ir |
| Iran, Islamic Republic of | |
| Dr Mohagheghi's Office | Recruiting |
| Tehran, Iran, Islamic Republic of | |
| Study Chair: | Kheirollah Gholami, M.Sc,PharmD | Tehran University of Medical Sciences |
| Study Director: | Zahra Jahangard-Rafsanjani, PharmD | Tehran University of Medical Sciences |
| Principal Investigator: | Arash Rashidian, M.D , Ph.D | Tehran University of Medical Sciences |
More Information
No publications provided
| Responsible Party: | Tehran University of Medical Sciences |
| ClinicalTrials.gov Identifier: | NCT01525108 History of Changes |
| Other Study ID Numbers: | 90-04-156-15281 |
| Study First Received: | January 30, 2012 |
| Last Updated: | April 5, 2012 |
| Health Authority: | Iran: Ministry of Health |
Keywords provided by Tehran University of Medical Sciences:
|
Medication adherence Blood pressure Home-based blood pressure measurement |
Blood Pressure Determination Blood Pressure Monitors Blood Pressure Monitoring, Ambulatory |
Additional relevant MeSH terms:
|
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013